Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury

Abstract

The cyclin-dependent kinase inhibitor p27Kip1 controls cell proliferation in response to normal mitogenic stimuli. We show here that p27Kip1 also safeguards against excessive cell proliferation in specific pathophysioiogic settings. We used experimental glomerulonephritis as a paradigm for immune mediated inflammation and ureteral obstruction as a model for non-immune mediated inflammation. Renal function was substantially decreased in nephritic p27−/− mice compared with control mice, and this was associated with increased glomerular cell proliferation, apoptosis and matrix protein accumulation. Tubular epithelial cell proliferation and apoptosis was also increased in p27−/− mice following ureteral obstruction. p27Kip1 may have a general role in protecting cells and tissues from inflammatory injury.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Bisgaard, H.C. & Thorgeirsson, S.S. Hepatic regeneration. The role of regeneration in pathogenesis of chronic liver disease. Clin. Lab. Med. 16, 325–339 (1996).

    Article  PubMed  CAS  Google Scholar 

  2. MacLeod, D.C. et al. Proliferation and extracellular matrix synthesis of smooth muscle cells from cultured human coronary atherosclerotic and restenotic lesions. J. Am. Coll. Cardiol. 23, 59–65 (1994).

    Article  PubMed  CAS  Google Scholar 

  3. Johnson, R.J. The glomerular response to injury: Progression or resolution? Kidney Int. 45, 1769–1782 (1994).

    Article  PubMed  CAS  Google Scholar 

  4. Couser, W.G. & Johnson, R.J. Mechanisms of progressive renal disease in glomerulonephritis. Am. J. Kidney Dis. 23, 193–198 (1994).

    Article  PubMed  CAS  Google Scholar 

  5. Morgan, D.O. Principles of CDK regulation. Nature 374, 131–134 (1995).

    Article  PubMed  CAS  Google Scholar 

  6. Sherr, C.J. & Roberts, J.M. Inhibitors of mammalian G1 cyclin-dependent kinases. Genes & Dev. 9, 1149–1163 (1995).

    Article  CAS  Google Scholar 

  7. Nourse, J. et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372, 570–573 (1994).

    Article  PubMed  CAS  Google Scholar 

  8. Polyak, K. et al. Cloning of p27Kip1Kip1, a cyclin-dependent kinase inhibitor and potential mediator of extracellular antimitogenic signals. Cell 78, 59–66 (1994).

    Article  PubMed  CAS  Google Scholar 

  9. Coats, S., Flanagan, W.M., Nourse, J. & Roberts, J.M. Requirement of p27Kipl for restriction point control of the fibroblast cell cycle. Science 272, 877–880 (1996).

    Article  PubMed  CAS  Google Scholar 

  10. Shankland, S.J. et al. Mesangial cell proliferation mediated by PDCF and bFGF is determined by levels of the cyclin kinase inhibitor p27Kip1 . Kidney Int. 51, 1088–1099 (1997).

    Article  PubMed  CAS  Google Scholar 

  11. Fero, M.L. et al. A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice. Cell 85, 733–744 (1996).

    Article  PubMed  CAS  Google Scholar 

  12. Nakayama, K. et al. Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85, 707–720 (1996).

    Article  PubMed  CAS  Google Scholar 

  13. Kiyokawa, H. et al. Enhanced growth in mice lacking the cyclin-dependent kinase inhibitor function of p27Kip1 . Cell 85, 721–732 (1996).

    Article  PubMed  CAS  Google Scholar 

  14. Atkins, R.C., Nikolic-Paterson, D.J., Song, Q. & Lan, H.Y. Modulators of crescentic glomerulonephritis. J. Am. Soc. Nephrol. 7, 2271–2278 (1996).

    PubMed  CAS  Google Scholar 

  15. Truong, L.D. et al. Cell apoptosis and proliferation in experimental obstructive uropathy. Kidney Int. 50, 200–207 (1996).

    Article  PubMed  CAS  Google Scholar 

  16. Wang, J. & Walsh, K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273, 359–361 (1996).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  17. Porter, P.L. et al. Expression of cell-cycle regulators p27Kp1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222–225 (1997).

    Article  PubMed  CAS  Google Scholar 

  18. Catzavelos, C. et al. Decreased levels of the cell cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer. Nature Med. 3, 227–230 (1997).

    Article  PubMed  CAS  Google Scholar 

  19. Loda, M. et al. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas. Nature Med. 3, 231–234 (1997).

    Article  PubMed  CAS  Google Scholar 

  20. Salant, D.J., Darby, C. & Couser, W.C. Experimental membranous glomerulonephritis in rats. j, Clin. Invest. 66, 71–81 (1980).

    Article  CAS  Google Scholar 

  21. Couser, W.G.D.C., Salant, D.J., Adler, S., Stilmant, M.M. & Lowenstein, L.M. anti-GBM antibody-induced proteinuria in isolated perfused rat kidney. Am.J. Physiol. 249, 241–250 (1985).

    Google Scholar 

  22. Butler, A.R. Jaffe reaction. Identifcation of the colored species. Clin. Chim. Ada. 59, 227–232 (1975).

    Article  CAS  Google Scholar 

  23. Bradley G.M. & Benson E.S. Examination of the Urine. (WB Saunders, 1974).

  24. Shankland, S.J. et al. Changes in cell cycle protein expression during experimental mesangial proliferative glomerulonephritis. Kidney Int. 50, 1230–1239 (1996).

    Article  PubMed  CAS  Google Scholar 

  25. Baker, P.J. et al. Depletion of C6 prevents development of proteinuria in experimental membranous nephropathy in rats. Am. J. Pathol. 135, 185–194 (1989).

    PubMed  PubMed Central  CAS  Google Scholar 

  26. Shankland, S.J. et al. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo. Kidney Int. 52, 404–413 (1997).

    Article  PubMed  CAS  Google Scholar 

  27. Kerr, P.G., Lan, L.H. & Atkins, R.C. Diseases of The Kidney 6th edn (ed. Schrier RW, G.C.) 1619–1644 (Little, Brown, and Company, 1997).

  28. Thomas, S.E. et al. Tubulointerstitial disease in aging: evidence for underlying peritubular capillary damage, a potential role for renal ischemia. J. Am. Soc. Nephrol. 9, 231–242 (1998).

    PubMed  CAS  Google Scholar 

  29. Huang, X.R., Tipping, P.G., Li, S. & Holdsworth, S.R. TH1 responsiveness to nephritogenic antigens determines susceptibility to crescentic glomerulonephritis in mice. Kidney Int. 51, 94–103 (1997).

    Article  PubMed  CAS  Google Scholar 

  30. Wolf, N.S., Kone, A., Priestley, G.V. & Bartelmez, S.H. In vivo and in vitro characterization of long-term repopulating primitive hematopoietic cells isolated by sequential Hoechst 33342-rhodamine 123 FACS selection. Exp. Hematol. 21, 614–622 (1993).

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ophascharoensuk, V., Fero, M., Hughes, J. et al. The cyclin-dependent kinase inhibitor p27Kip1 safeguards against inflammatory injury. Nat Med 4, 575–580 (1998). https://doi.org/10.1038/nm0598-575

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm0598-575

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing